4.2 Article

Effects of lubiprostone on human uterine smooth muscle cells

Journal

PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume 86, Issue 1-4, Pages 56-60

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2008.03.001

Keywords

membrane potential; lubiprostone; EP1; prostaglandin; Ca2+; cAMP; uterine smooth muscle; prostaglandin receptors; SC-51322

Ask authors/readers for more resources

Lubiprostone, a bicyclic fatty acid derivative and member of a new class of compounds called prostones, locally activates ClC-2 Cl- channels without activation of prostaglandin receptors. The present study was specifically designed to test and compare lubiprostone and prostaglandin effects at the cellular level using human uterine smooth muscle cells. Effects on [Ca2+](i), membrane potential and [cAMP](i) in human uterine smooth muscle cells were measured. 10 nM lubiprostone significantly decreased [Ca2+](i) from 188 to 27 nM, which was unaffected by 100 nM SC-51322, a prostaglandin EP receptor antagonist. In contrast 10 nM PGE(2) and PGE(1) both increased [Ca2+](i) 3-5-fold which was blocked by SC-51322. Similarly, lubiprostone and prostaglandins had opposite/different effects on membrane potential and [cAMP]i. Lubiprostone caused SC-51322-insensitive membrane hyperpolarization and no effect on [cAMP](i). PGE(2) and PGE(1) both caused SC-51322-sensitive membrane depolarization and increased [cAMF](i). Lubiprostone has fundamentally different cellular effects from prostaglandins that are not mediated by EP receptors. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available